Trial Profile
Comparative Study of the Effects of Telmisartan and Nebivolol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Patients With Arterial Hypertension
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TELNEB
- 11 Mar 2014 New trial record